Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

ADAPALENE-BNZYL PEROX 0.1-2.5%

Adapalene and Benzoyl Peroxide
$0.3038per GM

Strength

.1; 2.5 g/100g; g/100g

Manufacturer

Padagis Israel Pharmaceuticals Ltd

NDC

45802084601

Classification

Generic

Dosage Form

GEL

Route

TOPICAL

Last Updated

4/22/2026

Active Ingredients

ADAPALENE; BENZOYL PEROXIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA205033

On Market Since

1/24/2018

Pharmacological Classes

Retinoid
Retinoids

Price History

1W

0.0%

1M

+6.5%

3M

-3.1%

6M

-24.4%

1Y

-29.1%

3Y

-66.7%

5Y

-71.8%

All

-95.7%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Related Drugs

Same classification

ADAPALENE-BNZYL PEROX 0.1-2.5%
Generic
21922005250•Encube Ethicals, Inc.
$0.3038
per GM
ADAPALENE-BNZYL PEROX 0.1-2.5%
Generic
51672136403•Sun Pharmaceutical Industries Inc.
$0.3038
per GM
ADAPALENE-BNZYL PEROX 0.1-2.5%
Generic
68462030147•Glenmark Pharmaceuticals Inc., USA
$0.3038
per GM
ADAPALENE 0.1% GEL
Generic
00536141226•Rugby Laboratories
$0.3555
per GM
ADAPALENE 0.1% GEL
Generic
51672215006•Sun Pharmaceutical Industries Inc.
$0.3555
per GM
ADAPALENE 0.1% GEL
Generic
00536141220•Rugby Laboratories
$0.4317
per GM
GNP ADAPALENE 0.1% GEL
Generic
46122076836•AmerisourceBergen
$0.4317
per GM
ADAPALENE 0.1% GEL
Generic
51672215001•Sun Pharmaceutical Industries Inc.
$0.4317
per GM
ADAPALENE 0.3% GEL
Generic
00472012645•Actavis Pharma, Inc.
$0.5076
per GM
ADAPALENE 0.3% GEL
Generic
21922005106•Encube Ethicals, Inc.
$0.5076
per GM

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy